The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
NCT ID: NCT05766787
Last Updated: 2024-06-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
190 participants
INTERVENTIONAL
2023-03-29
2023-06-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
NCT05431478
Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT06469242
Clinical Performance of a Silicone Hydrogel for Daily Disposable Wear
NCT03095027
Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses
NCT05050578
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
NCT03586167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LID022821, then AOHP
Serafilcon A contact lenses worn first, with senofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE will be used for daily cleaning and disinfection.
Serafilcon A contact lenses
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
Senofilcon A contact lenses
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
CLEAR CARE
Hydrogen peroxide based contact lens cleaning and disinfecting solution
AOHP, then LID022821
Senofilcon A contact lenses worn first, with serafilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE will be used for daily cleaning and disinfection.
Serafilcon A contact lenses
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
Senofilcon A contact lenses
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
CLEAR CARE
Hydrogen peroxide based contact lens cleaning and disinfecting solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serafilcon A contact lenses
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
Senofilcon A contact lenses
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
CLEAR CARE
Hydrogen peroxide based contact lens cleaning and disinfecting solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best Corrected Visual Acuity (BCVA) of 20/25 Snellen (0.10 logMAR) or better in each eye.
* Willing to stop wearing habitual contact lenses for the duration of study participation.
Exclusion Criteria
* Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator.
* Habitual wear of AOHP contact lenses.
* Habitual wear of any daily disposable contact lenses.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead Alcon Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kurata Eyecare Center
Los Angeles, California, United States
Dr. Elsa Pao, OD
Oakland, California, United States
Pacific Rims Optometry
San Francisco, California, United States
Omega Vision Center P.A.
Longwood, Florida, United States
Kindred Optics at Maitland Vision
Maitland, Florida, United States
Vision Health Institute
Orlando, Florida, United States
Tallahassee Eye Center
Tallahassee, Florida, United States
Heart of America Eye Care
Shawnee Mission, Kansas, United States
The Eye Doctors Inc
Eden Prairie, Minnesota, United States
Complete Eye Care of Medina
Medina, Minnesota, United States
SUNY College of Optometry Clinical Vision Research Center
New York, New York, United States
ProCare Vision Centers, Inc.
Granville, Ohio, United States
West Bay Eye Associates
Warwick, Rhode Island, United States
Optometry Group, PLLC
Memphis, Tennessee, United States
Total Eye Care PA
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLL949-C024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.